FDA - Food and Drug Administration

10/16/2024 | Press release | Distributed by Public on 10/16/2024 17:28

STASKA Pharmaceuticals (Ascorbic Acid Solution for Injection/STASKA Pharmaceuticals Inc.) Recall reason: Device & Drug Safety – Presence of glass particulates

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.